Facility
GSK Vaccines – Rixensart R&D
Operated by GSK →BE · Walloon Brabant
GSK adjuvant R&D and development campus; original site for AS01 adjuvant system development; works with Wavre on adjuvant formulation and scale-up
0
Inputs produced
0
Goods downstream
0
Incidents on record
0
Stories